Both topical and oral antifungals are effective agents in the treatment of Pityrosporum folliculitis (PF). Oral antifungals have the advantage of dramatic, immediate clearing of the lesions and are the most effective treatment. 
Patients have been successfully treated with oral pulse itraconazole and weekly fluconazole. M sympodialis is highly sensitive to terbinafine, while other species are more resistant to treatment with this medication. 
A course of oral ketoconazole  and topical ketoconazole shampoo is currently the recommended treatment.  Oral medication should be discontinued when the lesions resolve. Because relapse almost always occurs when treatment is withdrawn, topical ketoconazole is indefinitely continued after successful initial treatment with oral medication.
Other topicals that are used to treat Pityrosporum folliculitis are ciclopirox olamine cream, econazole cream, alcohol and salicylic acid solution (with or without benzoic acid 5%), propylene glycol 50% in water, and selenium sulfide shampoo.  Other topical treatments with some reported success include tea tree oil, honey, tacrolimus, and cinnamic acid. 
In cases associated with antibiotic use, discontinuing the antibiotic may be helpful.
Tetracycline does not help in Pityrosporum folliculitis, and it may exacerbate the condition by further destroying the normal bacterial skin flora and allowing further spread of Malassezia yeasts.
Other studies suggest topical photodynamic therapy with methyl aminolevulinate may be a potential therapy for recalcitrant Malassezia folliculitis. 
No consultations are necessary in Pityrosporum folliculitis.
Advise patients with Pityrosporum folliculitis to avoid predisposing factors such as emollients, occlusive topicals, occlusive nylon clothing, immunosuppressants, steroids, and antibiotics.
Regular clinical follow-up may be necessary in Pityrosporum folliculitis (PF) to monitor the patient's condition and refill prescriptions.
What would you like to print?